AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Kamada Ltd
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SFD0K6
7.77▲ 0.04 (0.52%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
7.73
Day's Range
7.68 – 7.80
52-Week Range
6.55 – 9.35
Volume
88.2K
Avg Volume
99.9K
Share Statistics
Shares Outstanding
Employees
462
Exchange
XNAS
Listed
2013-05-31
Share count as of December 31, 2025

Kamada Ltd (KMDA) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Kamada Ltd (KMDA)
What is Kamada Ltd's Market Cap?
Kamada Ltd's Market Cap is $448.2M, based on as-reported figures from SEC (XBRL) filings.
What is Kamada Ltd's Enterprise Value?
Kamada Ltd's Enterprise Value is $382.7M, based on as-reported figures from SEC (XBRL) filings.
What is Kamada Ltd's Trailing P/E?
Kamada Ltd's Trailing P/E is 22.2×, based on as-reported figures from SEC (XBRL) filings.
What is Kamada Ltd's Price / Sales?
Kamada Ltd's Price / Sales is 2.5×, based on as-reported figures from SEC (XBRL) filings.
What is Kamada Ltd's EV / Revenue?
Kamada Ltd's EV / Revenue is 2.1×, based on as-reported figures from SEC (XBRL) filings.
What is Kamada Ltd's EV / EBITDA?
Kamada Ltd's EV / EBITDA is 13.7×, based on as-reported figures from SEC (XBRL) filings.
What is Kamada Ltd's Revenue (TTM)?
Kamada Ltd's Revenue (TTM) is $180.5M, based on as-reported figures from SEC (XBRL) filings.
What is Kamada Ltd's Net Income (TTM)?
Kamada Ltd's Net Income (TTM) is $20.2M, based on as-reported figures from SEC (XBRL) filings.
What is Kamada Ltd's EBITDA?
Kamada Ltd's EBITDA is $27.9M, based on as-reported figures from SEC (XBRL) filings.
What is Kamada Ltd's Diluted EPS (TTM)?
Kamada Ltd's Diluted EPS (TTM) is 0.35, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · KMDAAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
Total revenues
Total cost of revenues
Gross profit
Research and development expenses
Selling and marketing expenses
General and administrative expenses
Other expense—
Operating income
Financial income
Income (expenses) in respect of currency exchange differences and derivatives instruments, net
Revaluation of long-term liabilities
Financial expense
Income before tax on income
Taxes on income
Net Income (Loss)